FDA Inspection 1224221 — Konstantinos Avraam, MD

Konstantinos Avraam, MD — FEI 3027596512

The FDA completed an inspection of Konstantinos Avraam, MD on Oct 20, 2023 in Antwerp. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 20, 2023
Fiscal Year
2024
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Antwerp (Belgium)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.